NCT01683396View on ClinicalTrials.gov

Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Osteoarthritis

Interventions

DRUG

Placebo

Solution for subcutaneous injection

DRUG

gevokizumab

Solution for subcutaneous injection

Trial Locations (27)

Unknown

Huntsville

Tucson

Little Rock

Roseville

Sacramento

Santa Monica

Van Nuys

Denver

Miami

Pinellas Park

Sarasota

Vero Beach

West Palm Beach

Wichita

Reno

New York

Rochester

Raleigh

Portland

Duncansville

Austin

Dallas

San Antonio

Waco

Charlottesville

Norfolk

Franklin

All Listed Sponsors

lead

XOMA (US) LLC

INDUSTRY

NCT01683396 - Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand | Biotech Hunter | Biotech Hunter